Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.

NCT03455387 · clinicaltrials.gov ↗

COMPLETED

Status

233

Enrollment

OTHER

Sponsor class

Conditions

Pre-Eclampsia
HELLP Syndrome
Fetal Death
Eclampsia
Placental Abruption
Fetal Growth Retardation, Antenatal

Interventions

DIAGNOSTIC_TEST: sampling of the serum marker sFlt1 and PlGF

Sponsor

Centre Hospitalier Metropole Savoie